Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Published in: Clinical Research in Cardiology 8/2021

01-08-2021 | Heart Failure | Review

Estimated plasma volume status in heart failure: clinical implications and future directions

Authors: Masatake Kobayashi, Nicolas Girerd, Kevin Duarte, Tahar Chouihed, Taishiro Chikamori, Bertram Pitt, Faiez Zannad, Patrick Rossignol

Published in: Clinical Research in Cardiology | Issue 8/2021

Login to get access

Abstract

Congestion is one of the main predictors of poor outcome in patients with heart failure (HF). Assessing and monitoring congestion is essential for optimizing HF therapy. Among the various available methods, serial measurements of estimated plasma volume (ePVS) using routine blood count and/or body weight (e.g., the Strauss, Duarte, Hakim formulas) may be useful in HF management. Further prospective study is warranted to determine whether ePVS can help optimize decongestion therapy (loop diuretics, mineralocorticoid receptor antagonists, SGLT2i) in various HF settings. This narrative review summarizes the recent evidence supporting the association of ePVS with clinical congestion and outcome(s) and discusses future directions for monitoring ePVS in HF.

Graphic abstract

Appendix
Available only for authorised users
Literature
1.
Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Perez-Calvo JI, Voors AA (2018) Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 258:185–191PubMedCrossRef
2.
Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P (2018) Ini-Crct GN and the EFHFG Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Fail 6:273–285PubMedCrossRef
3.
Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 62:e147–e239PubMedCrossRef
4.
Miller WL (2016) Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed. Circ Heart Fail 9:e002922PubMedCrossRef
5.
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure, A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82:1724–1729PubMedCrossRef
6.
Kalra PR, Anagnostopoulos C, Bolger AP, Coats AJS, Anker SD (2002) The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39:1901–1908PubMedCrossRef
7.
Nijst P, Verbrugge FH, Bertrand PB, Martens P, Dupont M, Drieskens O, Penders J, Tang WH, Mullens W (2017) Plasma volume is normal but heterogeneously distributed, and true anemia is highly prevalent in patients with stable heart failure. J Card Fail 23:138–144PubMedCrossRef
8.
Kaplan E, Puestow RC, Baker LA, Kruger S (1954) Blood volume in congestive heart failure as determined with iodinated human serum albumin. Am Heart J 47:824–838PubMedCrossRef
9.
10.
Miller WL, Mullan BP (2014) Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. JACC Heart Fail 2:298–305PubMedCrossRef
11.
Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38:963–968PubMedCrossRef
12.
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265–272PubMedPubMedCentralCrossRef
13.
Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G, and investigators ET (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401–1411PubMedPubMedCentralCrossRef
14.
van der Meer P, Postmus D, Ponikowski P, Cleland JG, O’Connor CM, Cotter G, Metra M, Davison BA, Givertz MM, Mansoor GA, Teerlink JR, Massie BM, Hillege HL, Voors AA (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973–1981PubMedCrossRef
15.
Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A, Clark AL, Cleland JGF (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail 21:904–916PubMedCrossRef
16.
Montero D, Lundby C, Ruschitzka F, Flammer AJ (2017) True anemia-red blood cell volume deficit-in heart failure: a systematic review. Circ Heart Fail 10(5):e003610PubMedCrossRef
17.
Androne AS, Hryniewicz K, Hudaihed A, Mancini D, Lamanca J, Katz SD (2004) Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93:1254–1259PubMedCrossRef
18.
Strobeck JE, Feldschuh J, Miller WL (2018) Heart failure outcomes with volume-guided management. JACC Heart Fail 6:940–948PubMedCrossRef
19.
Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC (1951) Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 30:862–868PubMedPubMedCentralCrossRef
20.
Dill DB, Costill DL (1974) Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37:247–248PubMedCrossRef
21.
Buffaloe GW, Heineken FG (1983) Plasma volume nomograms for use in therapeutic plasma exchange. Transfusion 23:355–357PubMedCrossRef
22.
Sprenger KB, Huber K, Kratz W, Henze E (1987) Nomograms for the prediction of patient’s plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher 3:185–190PubMedCrossRef
23.
Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P (2015) Prognostic Value of Estimated Plasma Volume in Heart Failure. JACC Heart Fail 3:886–893PubMedCrossRef
24.
RM. H. Plasmapheresis. In: I. D. JT, B. PG and I. TS, eds (2001). Handbook of dialysis, 3rd ed Philadelphia: Lippincott. Williams and Wilkins 236
25.
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, on the behalf of G-H and Val-He FTI, (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17(4):424–433
26.
Martens P, Nijst P, Dupont M, Mullens W (2019) The optimal plasma volume status in heart failure in relation to clinical outcome. J Cardiac Failure 25(4):240–248CrossRef
27.
Dworkin HJ, Premo M, Dees S (2007) Comparison of red cell and whole blood volume as performed using both chromium-51-tagged red cells and iodine-125-tagged albumin and using I-131-tagged albumin and extrapolated red cell volume. Am J Med Sci 334:37–40PubMedCrossRef
28.
International Committee for Standardization in Haematology (1980) Recommended methods for measurement of red-cell and plasma volume: international committee for standardization in haematology. J Nuclear Med Off Publ Soc Nuclear Med 21:793–800
29.
Molitoris BA, George AG, Murray PT, Meier D, Reilly ES, Barreto E, Sandoval RM, Rizk DV, Shaw AD, Peacock WF (2019) A novel fluorescent clinical method to rapidly quantify plasma volume. Cardiorenal Med 9:168–179PubMedCrossRef
30.
Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, Velmurugan S, Mendonca M, Rashid M, Kang S, Papalia F, Weissert S, Coats CJ, Thomas M, Kuskowski M, Cohn JN, Woldman S, Anand IS, Okonko DO (2015) Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 17:35–43PubMedCrossRef
31.
Fudim M, Miller WL (2018) Calculated estimates of plasma volume in patients with chronic heart failure-comparison with measured volumes. J Cardiac Failure 24(9):553–560CrossRef
32.
Dekkers CCJ, Sjostrom CD, Greasley PJ, Cain V, Boulton DW, Heerspink HJL (2019) Effects of the sodium-glucose co-transporter-2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes. Diabet Obesity Metab 21(12):2667–2673CrossRef
33.
Yoshihisa A, Abe S, Sato Y, Watanabe S, Yokokawa T, Miura S, Misaka T, Sato T, Suzuki S, Oikawa M, Kobayashi A, Yamaki T, Kunii H, Saitoh SI, Takeishi Y (2018) Plasma volume status predicts prognosis in patients with acute heart failure syndromes. Eur Heart J Acute Cardiovasc Care 7(4):330–338PubMedCrossRef
34.
Kataoka H (2017) Vascular expansion during worsening of heart failure: Effects on clinical features and its determinants. Int J Cardiol 230:556–561PubMedCrossRef
35.
Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, Drazner MH, Tang WHW, Pandey A (2019) Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. Eur J Heart Fail 21(5):634–642PubMedCrossRef
36.
Kobayashi M, Huttin O, Donal E, Duarte K, Hubert A, Le Breton H, Galli E, Fournet M, Mabo P, Schnell F, Leclercq C, Rossignol P, Girerd N (2020) Association of estimated plasma volume status with hemodynamic and echocardiographic parameters. Clin Res Cardiol 109(8):1060–1069PubMedCrossRef
37.
Almufleh A, Desai AS, Fay R, Ferreira JP, Buckley LF, Mehra MR, Rossignol P, Zannad F (2020) Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients. Eur J Heart Fail 22(10):1907–1911PubMedCrossRef
38.
Hayasaka K, Matsue Y, Kitai T, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Yoshioka K, Kuroda S, Kagiyama N, Yamaguchi T and Sasano T (2020) Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure. Eur Heart J Cardiovasc Imag
39.
Rossignol P, Menard J, Fay R, Gustafsson F, Pitt B, Zannad F (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58:1958–1966PubMedCrossRef
40.
Hamilton RW, Buckalew VM Jr (1984) Sodium, water, and congestive heart failure. Ann Intern Med 100:902–904PubMedCrossRef
41.
Ghali JK, Tam SW (2010) The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail 16:419–431PubMedCrossRef
42.
Miller WL, Mullan BP (2016) Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: are there differences? A pilot study. JACC Heart Fail 4:453–459PubMedCrossRef
43.
Takei M, Kohsaka S, Shiraishi Y, Goda A, Izumi Y, Yagawa M, Mizuno A, Sawano M, Inohara T, Kohno T, Fukuda K, Yoshikawa T, West Tokyo Heart Failure Registry I (2015) Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction. Circulat Heart Failure 8:527–532CrossRef
44.
Kobayashi M, Rossignol P, Ferreira JP, Aragao I, Paku Y, Iwasaki Y, Watanabe M, Fudim M, Duarte K, Zannad F, Girerd N (2019) Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. Clin Res Cardiol 108(5):549–561PubMedCrossRef
45.
Kobayashi M, Girerd N, Duarte K, Preud'homme G, Pitt B, Rossignol P (2020) Prognostic Impact of Plasma Volume Estimated from Hemoglobin and Hematocrit in Heart Failure with Preserved Ejection Fraction. Clin Res Cardiol. 109(11):1392–1401PubMedCrossRef
46.
Ergatoudes C, Schaufelberger M, Andersson B, Pivodic A, Dahlström U, Fu M (2019) Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol 108:1025–1033PubMedPubMedCentralCrossRef
47.
Streng KW, Nauta JF, Hillege HL, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Zannad F, Damman K, van der Meer P, Voors AA (2018) Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 271:132–139PubMedCrossRef
48.
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R, Gissi HF, Val-He FTI (2015) Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail 17:424–433PubMedCrossRef
49.
Huang CY, Lin TT, Wu YF, Chiang FT, Wu CK (2019) Long-term prognostic value of estimated plasma volume in heart failure with preserved ejection fraction. Sci Rep 9:14369PubMedPubMedCentralCrossRef
50.
Balderston JR, Shah KB, Paciulli SC, Gertz ZM (2018) Usefulness of estimated plasma volume at postdischarge follow-up to predict recurrent events in patients with heart failure. Am J Cardiol 122:1191–1194PubMedCrossRef
51.
Hudson SR, Chan D, Ng LL (2016) Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study. J R Soc Med 109:337–346PubMedPubMedCentralCrossRef
52.
Bilchick KC, Chishinga N, Parker AM, Zhuo DX, Rosner MH, Smith LA, Mwansa H, Blackwell JN, McCullough PA, Mazimba S (2017) Plasma volume and renal function predict six-month survival after hospitalization for acute decompensated heart failure. Cardiorenal Med 8:61–70PubMedPubMedCentralCrossRef
53.
Kobayashi M, Bercker M, Huttin O, Pierre S, Sadoul N, Bozec E, Chouihed T, Ferreira JP, Zannad F, Rossignol P, Girerd N (2020) Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study. Int J Cardiol 299:192–198PubMedCrossRef
54.
Fudim M, Lerman JB, Page C, Alhanti B, Califf RM, Ezekowitz JA, Girerd N, Grodin JL, Miller WL, Pandey A, Rossignol P, Starling RC, Tang WHW, Zannad F, Hernandez AF, O'Connor CM and Mentz RJ (2020) Plasma volume status and its association with in-hospital and post-discharge outcomes in decompensated heart failure. J Card Fail
55.
Maznyczka AM, Barakat MF, Ussen B, Kaura A, Abu-Own H, Jouhra F, Jaumdally H, Amin-Youssef G, Nicou N, Baghai M, Deshpande R, Wendler O, Kolvekar S, Okonko DO (2019) Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery. Heart 105:1020–1026PubMedCrossRef
56.
Adlbrecht C, Piringer F, Resar J, Watzal V, Andreas M, Strouhal A, Hasan W, Geisler D, Weiss G, Grabenwöger M, Delle-Karth G, Mach M (2020) The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation. Eur J Clin Invest 50:e13251PubMedCentralCrossRef
57.
Schaefer AK, Poschner T, Andreas M, Kocher A, Laufer G, Wiedemann D, Mach M (2020) Impact of subclinical congestion on outcome of patients undergoing mitral valve surgery. Biomedicines 8(9):363PubMedCentralCrossRef
58.
Chouihed T, Rossignol P, Bassand A, Duarte K, Kobayashi M, Jaeger D, Sadoune S, Buessler A, Nace L, Giacomin G, Hutter T, Barbe F, Salignac S, Jay N, Zannad F, Girerd N (2019) Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort. Clin Res Cardiol 108(5):563–573PubMedCrossRef
59.
Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH (2013) Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62:516–524PubMedPubMedCentralCrossRef
60.
Parrinello G, Greene SJ, Torres D, Alderman M, Bonventre JV, Di Pasquale P, Gargani L, Nohria A, Fonarow GC, Vaduganathan M, Butler J, Paterna S, Stevenson LW, Gheorghiade M (2015) Water and sodium in heart failure: a spotlight on congestion. Heart Fail Rev 20:13–24PubMedPubMedCentralCrossRef
61.
Davila C, Reyentovich A, Katz SD (2011) Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure. J Card Fail 17:1018–1022PubMedCrossRef
62.
Darawsha W, Chirmicci S, Solomonica A, Wattad M, Kaplan M, Makhoul BF, Abassi ZA, Azzam ZS, Aronson D (2016) Discordance between hemoconcentration and clinical assessment of decongestion in acute heart failure. J Card Fail 22:680–688PubMedCrossRef
63.
Rao VS, Ahmad T, Brisco-Bacik MA, Bonventre JV, Wilson FP, Siew ED, Felker GM, Anstrom KK, Mahoney DD, Bart BA, Tang WHW, Velazquez EJ, Testani JM (2019) Renal effects of intensive volume removal in heart failure patients with preexisting worsening renal function. Circ Heart Fail 12:e005552PubMedPubMedCentralCrossRef
64.
Ferreira JP, Chouihed T, Nazeyrollas P, Levy B, Seronde MF, Bilbault P, Braun F, Roul G, Kenizou D, Zannad N, Girerd N, Rossignol P (2018) Practical management of concomitant acute heart failure and worsening renal function in the emergency department. Eur J Emerg Med Off J Eur Soc Emerg Med 25:229–236CrossRef
65.
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei CL (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5:54–62PubMedCrossRef
66.
67.
68.
Davison BA, Metra M, Cotter G, Massie BM, Cleland JGF, Dittrich HC, Edwards C, Filippatos G, Givertz MM, Greenberg B, Ponikowski P, Voors AA, O’Connor CM, Teerlink JR (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 3:395–403PubMedCrossRef
69.
Davidov M, Kakaviatos N, Finnerty FA Jr (1967) Intravenous administration of furosemide in heart failure. JAMA 200:824–829PubMedCrossRef
70.
Guazzi MD, Agostoni P, Perego B, Lauri G, Salvioni A, Giraldi F, Matturri M, Guazzi M, Marenzi G (1994) Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. British heart journal 72:534–539PubMedPubMedCentralCrossRef
71.
Boyle A, Sobotka PA (2006) Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 12:247–249PubMedCrossRef
72.
Packer M, Kitzman DW (2018) Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2. JACC Heart Failure 6:633–639PubMedCrossRef
73.
Nakagawa H, Oberwinkler H, Nikolaev VO, Gaßner B, Umbenhauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M (2014) Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation. Circ Heart Failure 7:814–821PubMedCrossRef
74.
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995–2008PubMedCrossRef
75.
Rossignol P, Hernandez AF, Solomon SD, Zannad F (2019) Heart failure drug treatment. Lancet 393:1034–1044PubMedCrossRef
76.
Lambers Heerspink HJ, de Zeeuw D, Wie L, Leslie B, List J (2013) Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes Obes Metab 15:853–862PubMedCrossRef
77.
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J, Böhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukát A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O’Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjöstrand M, Langkilde AM (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008PubMedCrossRef
78.
Sano M, Goto S (2019) Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects. Circulation 139:1985–1987PubMedCrossRef
79.
Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI (2018) Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int 94:26–39PubMedCrossRef
80.
Tang WHW, Telukuntla KS, Mayuga KA (2018) Can Blood Volume Analysis-Guided Acute Heart Failure Therapy Improve Clinical Outcomes? JACC Heart Fail 6:949–950PubMedCrossRef
81.
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658–666PubMedCrossRef
82.
Vaduganathan M, Greene SJ, Fonarow GC, Voors AA, Butler J, Gheorghiade M (2014) Hemoconcentration-guided diuresis in heart failure. Am J Med 127:1154–1159PubMedCrossRef
83.
Rossignol P, Fay R, Girerd N, Zannad F (2020) Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge. ESC Heart Failure 7:1257–1263PubMedPubMedCentralCrossRef
84.
Okonko DO, Jouhra F, Abu-Own H, Filippatos G, Colet JC, Suki C, Mori C, Ponikowski P, Anker SD (2019) Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR-HF substudy. ESC Heart Fail 6:621–628PubMedPubMedCentralCrossRef
85.
Massari F, Scicchitano P, Iacoviello M, Passantino A, Guida P, Sanasi M, Piscopo A, Romito R, Valle R, Caldarola P, Ciccone MM (2019) Multiparametric approach to congestion for predicting long-term survival in heart failure. J Cardiol 75(1):47–52PubMedCrossRef
86.
Tamaki S, Yamada T, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kawai T, Seo M, Abe M, Nakamura J, Yamamoto K, Kayama K, Kawahira M, Tanabe K, Ueda K, Kimura T, Sakamoto D, Fukunami M (2019) Prognostic value of calculated plasma volume status in patients admitted for acute decompensated heart failure: a prospective comparative study with other indices of plasma volume. Circ Rep 1:361–371PubMedPubMedCentralCrossRef
Metadata
Title
Estimated plasma volume status in heart failure: clinical implications and future directions
Authors
Masatake Kobayashi
Nicolas Girerd
Kevin Duarte
Tahar Chouihed
Taishiro Chikamori
Bertram Pitt
Faiez Zannad
Patrick Rossignol
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 8/2021
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01794-8

Other articles of this Issue 8/2021

Clinical Research in Cardiology 8/2021 Go to the issue

Original Paper

Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response

Original Paper

Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patients

Original Paper

Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data

Original Paper

Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

Original Paper

Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE

Original Paper

Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF